Usefulness of Safinamide in Lewy Body Dementia
Antonio Oliveros‐Cid, Lisbed Rondon Moreno, Esther Sierrra Martinez, Pablo Navarro Beltran, Nicolas Fayed Miguel, Maria Angeles Cid Lopez, Fernando Jarauta Salvador, Antonio Oliveros‐Juste · 2025
Read Usefulness of Safinamide in Lewy Body Dementia by Antonio Oliveros‐Cid, Lisbed Rondon Moreno, Esther Sierrra Martinez, Pablo Navarro Beltran, Nicolas Fayed Miguel, Maria Angeles Cid Lopez, Fernando Jarauta Salvador, Antonio Oliveros‐Juste (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11712417.txt.
Description
Antonio Oliveros-Cid and co-authors report four Lewy body dementia cases where safinamide eased movement without harming thought, in work from twenty twenty-five. Lewy body dementia makes drug care delicate, above all for movement. Standard movement drugs can worsen thinking and behaviour in these patients. Safinamide acts through both dopamine and non-dopamine routes in the brain. It is licensed as an add-on for Parkinson disease with fluctuations.
Four clinic patients with the dementia start safinamide in the series. Their stiff posture, bent trunk, gait freezes, and fluctuations stand out. All had prior standard movement drug care plus memory drug care. Dose rises from a low start to a full dose over the course. Movement scores improve by a fair margin on average. Thinking and behaviour do not worsen in any of the four cases. The authors urge larger studies to confirm the signal.
Catalog record
| CREATOR | Antonio Oliveros‐Cid, Lisbed Rondon Moreno, Esther Sierrra Martinez, Pablo Navarro Beltran, Nicolas Fayed Miguel, Maria Angeles Cid Lopez, Fernando Jarauta Salvador, Antonio Oliveros‐Juste |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |